Valsartan as a prophylactic treatment against breast cancer development and niche activation: What molecular sequels follow chronic AT-1R blockade?

Autor: Mansour, Amira M.A., Khattab, Mahmoud M., El-Khatib, Aiman S., Awaad, Ashraf K., El-Refaie, Wessam M., El-Mezayen, Nesrine S.
Zdroj: In Life Sciences 15 September 2024 353
Databáze: ScienceDirect